Skip to main content

Month: December 2020

Argo Blockchain co-leads investment in Luxor Technologies

LONDON, Dec. 30, 2020 (GLOBE NEWSWIRE) — via InvestorWire: Argo Blockchain (OTC: ARBKF), the leading cryptocurrency miner based in the UK, is pleased to announce it will co-lead an investment in Luxor Technologies (“Luxor”), a hashrate management platform.As part of the deal, Argo will invest $100,000 USD into Luxor. Luxor intends to use the capital to make several key engineering hires to strengthen the development of its hashrate management platform. Luxor, which supports over 28,000 miners globally, has mined over $45m USD in cryptocurrency since inception. With this seed funding round, Luxor will further build out its proof-of-work software infrastructure.Proprietary technology developed by Luxor has the potential to supercharge returns for miners. Luxor’s Switch software product is a profit-switching algorithm that maximizes...

Continue reading

The term for the registration of the Articles of Association of INVL Baltic Real Estate is renewed

INVL Baltic Real Estate (hereinafter – „the Company“) informs that on 30 December 2020 the decision of the Vilnius City District Court has entered into force, by which the Court complied with the Company’s request to renew the term for registration of the Company’s Articles of Association.Due to quarantine announced during the spring in the country and the incompletely harmonized provisions of the Civil Code of the Republic of Lithuania and the Law on Collective Investment Undertakings of the Republic of Lithuania, under which the buy-back of the Company‘s shares process was carried out (which lasted until 9 November 2020), the Company is considered to have missed the 6-month term to submit to the Register of Legal Entities the new wording of the Company’s Articles of Association, approved by the General Meeting of Shareholders...

Continue reading

Atnaujintas terminas INVL Baltic Real Estate įstatų registravimui

„INVL Baltic Real Estate“ (toliau – „Bendrovė“) informuoja, kad 2020 m. gruodžio 30 d. įsiteisėjo Vilniaus miesto apylinkės teismo nutartis, kuria buvo tenkintas Bendrovės prašymas atnaujinti terminą Bendrovės įstatams įregistruoti.Dėl šių metų pavasarį šalyje paskelbto karantino ir ne iki galo suderintų Lietuvos Respublikos Civilinio Kodekso ir Lietuvos Respublikos kolektyvinio investavimo subjektų įstatymo nuostatų, pagal kurias iki 2020 m. lapkričio 9 d. buvo vykdomas privalomas Bendrovės akcijų išpirkimas, Bendrovė praleido 6 mėnesių terminą Juridinių asmenų registro tvarkytojui pateikti 2020 m. balandžio 9 d. vykusio visuotinio akcininkų susirinkimo patvirtintą naują Bendrovės įstatų redakciją. Todėl Bendrovė turėjo kreiptis į teismą su prašymu praleistą terminą atnaujinti. Plačiau apie 2020 m. balandžio 9 d. vykusį eilinį visuotinį...

Continue reading

Preliminary financial data of Ignitis Group for 11 months of 2020

Preliminary financial data of Ignitis Group (hereinafter – the Group) for 11 months of 2020:In January – November 2020, the Group generated revenue of EUR 1,089.8 million, which is 10.1 per cent. more compared to a respective period of 2019 (EUR 989.7 million). The Group’s revenue mainly increased as a result of higher revenue of the networks segment due to price of power distribution service, which is comprised of power transmission, distribution and public service obligations (PSO) components.The adjusted EBITDA indicator of the Group in January – November 2020 was equal to EUR 254.2 million, i.e. 7.0 per cent. more compared to a respective period of 2019 (EUR 237.6 million). The increase was driven by better result of networks segment due to growing value of regulated assets as a result of investments in the renewal of distribution...

Continue reading

An additional capital requirement has been set for Šiaulių bankas

Šiaulių Bankas AB, company code 112025254, address Tilžės str. 149, Šiauliai, Lithuania.Following the Supervisory Review and Evaluation Process (SREP) of Šiaulių Bankas AB, the European Central Bank set an additional capital requirement (P2R) of 1.6 per cent for Šiaulių Bankas AB, calculated according to the Pillar II. It will replace the previous additional capital requirement of 1.4 per cent. The main equity requirements applicable to the Bank are as follows:the total Tier 1 capital adequacy ratio (CET1) – 5.4 per cent.;Tier 1 capital adequacy ratio -7.2 per cent.;SREP total capital adequacy ratio (TSCR) – 9.6 per cent.;the overall capital adequacy ratio (OCR), including the combined capital buffer requirement – 12.6 per cent. Like other banks, due to Covid-19 impact Šiaulių Bankas may temporarily operate below this...

Continue reading

AB Šiaulių bankui nustatytas papildomas kapitalo reikalavimo dydis

AB Šiaulių bankas, įmonės kodas 112025254, buveinės adresas Tilžės g. 149, Šiauliai, Lietuva.Po AB Šiaulių banko priežiūrinio tikrinimo ir vertinimo proceso (SREP) Europos centrinis bankas AB Šiaulių bankui nustatė 1,6 proc. dydžio papildomą kapitalo reikalavimo dydį (P2R), apskaičiuotą pagal antrą pakopą (Pillar II). Jis pakeis iki tol galiojusį 1,4 proc. papildomo kapitalo reikalavimo dydį. Pagrindiniai Bankui taikomi nuosavų lėšų reikalavimai:bendro 1 lygio nuosavo kapitalo pakankamumo (CET1) koeficientas 5,4 proc.;1 lygio nuosavo kapitalo pakankamumo (Tier 1) koeficientas 7,2 proc.;SREP bendro kapitalo pakankamumo koeficientas (TSCR) 9,6 proc.;bendro kapitalo pakankamumo koeficientas (OCR), įvertinus jungtinio kapitalo rezervo reikalavimą 12,6 proc. Kaip ir kitiems bankams, dėl Covid-19 įtakos Šiaulių bankui laikinai leidžiama nesilaikyti...

Continue reading

CGG: CGG Converts a Vendor Loan into Shearwater Shares

CGG Converts a Vendor Loan into Shearwater SharesParis, December 30, 2020On December 29, 2020, CGG SA converted a Vendor Note issued by Shearwater Group on January 8, 2020 with the amount of 49,399,176 US Dollars into shareholding in Shearwater Geoservices Holding AS. Through this transaction, CGG SA subscribed to 1,958,248 Class A shares, corresponding to 3.30% of the total outstanding shares and 3.34% of the shares having voting rights in Shearwater Geoservices Holding AS. About CGGCGG (www.cgg.com) is a global geoscience technology leader. Employing around 4,000 people worldwide, CGG provides a comprehensive range of data, products, services and equipment that supports the discovery and responsible management of the Earth’s natural resources. CGG is listed on the Euronext Paris SA (ISIN: 0013181864).Contacts

Continue reading

CGG: CGG Convertit Un Crédit Vendeur en Actions Shearwater

CGG Convertit Un Crédit Vendeur en Actions ShearwaterParis, France – le 30 décembre 2020CGG annonce la conversion le 29 décembre 2020, d’un « Crédit Vendeur » émis par Shearwater Geoservices Holding AS (SGS) « Shearwater », le 8 janvier 2020 pour un montant de 49 399 176 US$ en une participation dans SGS. Dans le cadre de cette transaction, CGG a souscrit à 1 958 248 actions de catégorie A, ce qui correspond à 3,30 % du total des actions en circulation et à 3,34 % des actions de SGS détenant des droits de vote.A propos de CGG :CGG (www.cgg.com) est un leader technologique mondial spécialisé dans les géosciences. Avec environ 4 000 employés dans le monde, CGG fournit une gamme complète de données, de services et d’équipements pour la découverte et le développement responsables des ressources naturelles. CGG est coté sur Euronext...

Continue reading

CytoDyn to Hold Webcast on January 6 to Provide Timelines for Clinical and Regulatory Developments, Submission of 4 HIV BLAs and EUA Requests for COVID in Different Countries

VANCOUVER, Washington, Dec. 29, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Wednesday, January 6, 2021.Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities:1) BLA submissions to Health Canada, MHRA, EMA, and US FDA2) HIV prevention trial/monotherapy trial3) Potential revenue...

Continue reading

Hofseth Biocare ASA: Disclosure of large shareholdings in Hofseth BioCare ASA

Hofseth International AS (“HI”), has today transferred all shares from four wholly owned subsidiaries, Hofseth AS, Seafood Farmers of Norway AS, Hofseth Aalesund AS and Hofseth Logistics AS, to HI, and hence surpassed a threshold for disclosure of large shareholdings. The transfer price is NOK 9.20 per share, equal to the closing price on 29 December 2020.After the transaction, HI’s total shareholding is 58,881,778 shares, equal to 16.59 % of the total outstanding shares and voting rights in Hofseth BioCare ASA.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 936 32 966E-mail: joo@hofsethbiocare.noAbout Hofseth BioCare ASA:HBC is a Norwegian biotech company that develops high-value ingredients and finished products currently targeting the consumer health market. Research is ongoing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.